Nov 30, 2024
A breakthrough cancer immunotherapy is now taking aim at autoimmune disease
Posted by Shubham Ghosh Roy in categories: biotech/medical, innovation
Chimeric antigen receptor T-cell (CAR-T) therapy, already approved for certain blood cancers, is generating excitement in early tests against autoimmune diseases. Designed to wipe out a whole class of immune cells, the treatment holds promise but comes with potentially serious risks.